Terms: = Endocrine gland cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
36 results:
1. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD
Huang H; Wang S; Xia H; Zhao X; Chen K; Jin G; Zhou S; Lu Z; Chen T; Yu H; Zheng X; Huang H; Lan L
Cancer Lett; 2024 Apr; 588():216806. PubMed ID: 38467179
[TBL] [Abstract] [Full Text] [Related]
2. Nanoparticle Targeting in Chemo-Resistant Ovarian cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Wang Y; Calvert AE; Cardenas H; Rink JS; Nahotko D; Qiang W; Ndukwe CE; Chen F; Keathley R; Zhang Y; Cheng JX; Thaxton CS; Matei D
Adv Sci (Weinh); 2024 Apr; 11(13):e2305212. PubMed ID: 38263873
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of p300 increases cytotoxicity of cisplatin in pancreatic cancer cells.
Bugbee T; Gathoni M; Payne C; Blubaugh M; Matlock K; Wixson T; Lu A; Stancic S; Chung PA; Palinski R; Wallace N
Gene; 2023 Dec; 888():147762. PubMed ID: 37666373
[TBL] [Abstract] [Full Text] [Related]
4. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway.
Wang HC; Luo CW; Chen TY; Chen YZ; Fang SY; Lai CY; Hung WC; Wu CC; Chen LT; Liu YC; Pan MR
Life Sci; 2022 Dec; 311(Pt A):121135. PubMed ID: 36349605
[TBL] [Abstract] [Full Text] [Related]
5. Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance.
Cheng A; Rao Q; Liu Y; Huang C; Li J; Huo C; Lin Z; Lu H
Gynecol Oncol; 2022 Dec; 167(3):502-512. PubMed ID: 36270832
[TBL] [Abstract] [Full Text] [Related]
6. Patterns and Impact of Fragmented Care in Stage II and III Gastric cancer.
Rhodin KE; Raman V; Eckhoff A; Liu A; Creasy J; Nussbaum DP; Blazer DG
Ann Surg Oncol; 2022 Sep; 29(9):5422-5431. PubMed ID: 35723791
[TBL] [Abstract] [Full Text] [Related]
7. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.
He Z; Wang J; Zhu C; Xu J; Chen P; Jiang X; Chen Y; Jiang J; Sun C
Cancer Lett; 2022 Nov; 548():215751. PubMed ID: 35718269
[TBL] [Abstract] [Full Text] [Related]
8. The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Ji C; Xu W; Ding H; Chen Z; Shi C; Han J; Yu L; Qiao N; Zhang Y; Cao X; Zhou X; Cheng H; Feng H; Luo C; Li Z; Zhou B; Ye Z; Zhao Y
J Clin Endocrinol Metab; 2022 May; 107(6):e2291-e2300. PubMed ID: 35247260
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer.
Ding H; Pei Y; Li Y; Xu W; Mei L; Hou Z; Guang Y; Cao L; Li P; Cao H; Bian J; Chen K; Luo C; Zhou B; Zhang T; Li Z; Yang Y
Bioorg Med Chem; 2021 Dec; 52():116512. PubMed ID: 34801827
[TBL] [Abstract] [Full Text] [Related]
10. C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer.
Ono H; Kato T; Murase Y; Nakamura Y; Ishikawa Y; Watanabe S; Akahoshi K; Ogura T; Ogawa K; Ban D; Kudo A; Akiyama Y; Tanaka S; Ito H; Tanabe M
Sci Rep; 2021 May; 11(1):10078. PubMed ID: 33980911
[TBL] [Abstract] [Full Text] [Related]
11. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
12. A Novel E2F1-ep300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in Pancreatic cancer Cells Carrying Oncogenic KRAS.
Ropolo A; Catrinacio C; Renna FJ; Boggio V; Orquera T; Gonzalez CD; Vaccaro MI
Front Endocrinol (Lausanne); 2020; 11():411. PubMed ID: 32655498
[TBL] [Abstract] [Full Text] [Related]
13. Risk of malignancy and neoplasia predicted by three molecular testing platforms in indeterminate thyroid nodules on fine-needle aspiration.
Partyka KL; Trevino K; Randolph ML; Cramer H; Wu HH
Diagn Cytopathol; 2019 Sep; 47(9):853-862. PubMed ID: 31245935
[TBL] [Abstract] [Full Text] [Related]
14. Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells.
Sun NK; Kohli A; Huang SL; Chang TC; Chao CC
J Cell Physiol; 2019 Jun; 234(6):8760-8775. PubMed ID: 30317630
[TBL] [Abstract] [Full Text] [Related]
15. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract] [Full Text] [Related]
16. MIR-92 stimulates VEGF by inhibiting von Hippel-Lindau gene product in epithelial ovarian cancer.
Guo FJ; Shao YP; Wang YP; Jin YM; Liu SS; Wang QY
J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):615-624. PubMed ID: 28952293
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer.
McGinn O; Gupta VK; Dauer P; Arora N; Sharma N; Nomura A; Dudeja V; Saluja A; Banerjee S
Sci Rep; 2017 Aug; 7(1):7872. PubMed ID: 28801636
[TBL] [Abstract] [Full Text] [Related]
18. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
[TBL] [Abstract] [Full Text] [Related]
19. Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.
Cianfrocca R; Tocci P; Rosanò L; Caprara V; Sestito R; Di Castro V; Bagnato A
Oncotarget; 2016 Apr; 7(14):17790-804. PubMed ID: 26909598
[TBL] [Abstract] [Full Text] [Related]
20. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract] [Full Text] [Related]
[Next]
